Jinhai Tang

Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles

Yang Wu, Yu Zhang, Wei Zhang et al. · Colloids and Surfaces B Biointerfaces · 2015 · 99 citations

Pharmacy, Pharmaceutics, Pharmacology +16

Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

Jiong Wu, Zefei Jiang, Zhenzhen Liu et al. · BMC Medicine · 2022 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression of the PXR gene in various types of cancer and drug resistance

Enqi Qiao, Minghua Ji, Rong Ma et al. · Oncology Letters · 2013 · 68 citations · Full text

Medicine, Oncology, Pharmacology +13

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

Li Wang, Jianwei Lu, Rong Ma et al. · Molecular Medicine Reports · 2014 · 59 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention

Fei Wang, Liyuan Liu, Shude Cui et al. · The Oncologist · 2017 · 50 citations · Full text

Medicine, Endocrinology, Oncology +15